Dharmesh Shah
-
BDR Receives DCGI Approval for the Launch of Favipiravir to Treat COVID-19 in India
Mumbai : BDR Pharmaceuticals today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma…
Read More »